Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Non-Current Deferred Tax Liability (2018 - 2024)

Historic Non-Current Deferred Tax Liability for BioNexus Gene Lab (BGLC) over the last 7 years, with Q3 2024 value amounting to $13646.0.

  • BioNexus Gene Lab's Non-Current Deferred Tax Liability fell 5274.93% to $13646.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $13646.0, marking a year-over-year decrease of 5274.93%. This contributed to the annual value of $12255.0 for FY2023, which is 6029.61% down from last year.
  • BioNexus Gene Lab's Non-Current Deferred Tax Liability amounted to $13646.0 in Q3 2024, which was down 5274.93% from $11918.0 recorded in Q2 2024.
  • Over the past 5 years, BioNexus Gene Lab's Non-Current Deferred Tax Liability peaked at $30866.0 during Q4 2022, and registered a low of $1796.0 during Q3 2021.
  • Over the past 5 years, BioNexus Gene Lab's median Non-Current Deferred Tax Liability value was $19593.5 (recorded in 2022), while the average stood at $17840.3.
  • As far as peak fluctuations go, BioNexus Gene Lab's Non-Current Deferred Tax Liability skyrocketed by 145212.36% in 2022, and later crashed by 6115.78% in 2024.
  • BioNexus Gene Lab's Non-Current Deferred Tax Liability (Quarter) stood at $1872.0 in 2020, then soared by 1417.95% to $28416.0 in 2021, then grew by 8.62% to $30866.0 in 2022, then tumbled by 60.3% to $12255.0 in 2023, then increased by 11.35% to $13646.0 in 2024.
  • Its Non-Current Deferred Tax Liability stands at $13646.0 for Q3 2024, versus $11918.0 for Q2 2024 and $11916.0 for Q1 2024.